Description
Chrysomycin A (Chr-A), an antibiotic, can be obtained from Streptomyces. Chrysomycin A exhibits antitumor and anti-tuberculous and MRSA activities. As for glioblastoma, Chrysomycin A inhibits the proliferation, migration, and invasion of cancer cells through the Akt/GSK-3β/β-catenin signaling pathway.
Synonyms
Albacarcin V, MLS002701849, NSC354844, 1,5-anhydro-6-deoxy-1-(8-ethenyl-1-hydroxy-10,12-dimethoxy-6-oxo-6h-dibenzo[c,h]chromen-4-yl)-3-c-methylhexitol, 82196-88-1, VIRENOMYCIN V, AC1Q6MMD, AC1L3VB3, KST-1B9536, AR-1B8017, NSC613946, NSC 354844, NSC-354844, NSC-613946, NCI60_003193, SMR001565441, 4-(6-Deoxy-3-C-methyl-.beta.-gulopyranosyl)-8-vinyl-1-hydroxy-10,12-dimethoxy-6H-benzo[d]naphtho[1,2-b]pyran-6-one (chrysomycin A), 6H-Benzo(d)naphtho(1,2-b)pyran-6-one, 4-(6-deoxy-3-C-methyl-beta-L-gulopyranosyl)-8-ethenyl-1-hydroxy-10,12-dimethoxy-, 6H-Benzo[d]naphtho[1, 4-(6-deoxy-3-C-methyl-.beta.-D-gulopyranosyl)-8-ethenyl-1-hydroxy-10,12-dimethoxy-, 6H-Benzo[d]naphtho[1,4-(6-deoxy-3-C-methyl-.beta.-D-gulopyranosyl-8-ethenyl-1-hydroxy-10,12-dimethoxy-
IUPAC Name
8-ethenyl-1-hydroxy-10,12-dimethoxy-4-(3,4,5-trihydroxy-4,6-dimethyloxan-2-yl)naphtho[1,2-c]isochromen-6-one